Ferumoxytol for iron deficiency anemia in patients undergoing hemodialysis. The FACT randomized controlled trial

Background: Patients with chronic kidney disease (CKD) undergoing dialysis often require intravenous iron for iron deficiency anemia (IDA). Materials and methods: The Ferumoxytol for Anemia of CKD Trial (FACT), a randomized, multicenter, open-label, phase 4 study, compared the long-term safety and e...

Descripción completa

Detalles Bibliográficos
Autores principales: Macdougall, Iain C., Strauss, William E., Dahl, Naomi V., Bernard, Kristine, Li, Zhu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dustri-Verlag Dr. Karl Feistle 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6434426/
https://www.ncbi.nlm.nih.gov/pubmed/30802204
http://dx.doi.org/10.5414/CN109512

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6434426/
https://www.ncbi.nlm.nih.gov/pubmed/30802204
http://dx.doi.org/10.5414/CN109512

Ejemplares similares